Check Johnson & Johnson market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$426.8B
EPS (TTM)
10.8543
Dividend Yield
2.93%
Quarterly Earnings Growth YOY
0.19%
PE Ratio (TTM)
18.97
Industry PE ratio
17.391111111111112
P/B Ratio
18.9722
PEG Ratio
1.0175
EBITDA
30.3B
Revenue (TTM)
90.6B
Profit Margin
25.00%
Return On Equity TTM
30.21%
Track how Johnson & Johnson P/E has moved over time to understand its valuation trends.
Johnson & Johnson in the last 5 years
Lowest (14.19x)
June 30, 2024
Industry (17.39x)
September 18, 2025
Today (18.97x)
September 18, 2025
Highest (19.45x)
March 31, 2021
Today’s Price to Earnings Ratio: 18.97x
Compare market cap, revenue, PE, and other key metrics of Johnson & Johnson with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $426.8B | 18.78% | 18.97 | 25.00% | |
BUY | $375.3B | 16.71% | 24.63 | 18.95% | |
HOLD | $136.7B | -34.34% | 12.72 | 16.84% |
The Johnson & Johnson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Johnson & Johnson investment value today
Current value as on today
₹1,10,653
Returns
₹10,653
(+10.65%)
Returns from Johnson & Johnson Stock
₹5,700 (+5.7%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 28 analysts
53.57%
Buy
46.43%
Hold
0.00%
Sell
Based on 28 analysts, 53.57% of analysts recommend a 'BUY' rating for Johnson & Johnson. Average target price of $177.9
Get share price movements and forecasts by analysts on Johnson & Johnson.
What analysts predicted
1.28%UPSIDE
Target Price
$177.9
Current Price
$175.62
Analyzed by
28 Analysts
Target
$177.90
Johnson & Johnson target price $177.9, a slight upside of 1.28% compared to current price of $175.62. According to 28 analysts rating.
Investment in Johnson & Johnson Shares on INDmoney has grown by 24.72% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:24.72% versus previous 30 day period
Search interest for Johnson & Johnson Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 September
Wed, 06:23 PM
-Johnson & Johnson's icotrokinra shows superior skin clearance in psoriasis trials compared to Bristol Myers Squibb's Sotyktu.
Thu, 06:23 AM
-Johnson & Johnson reports Q2 results with $23.7 billion sales, raising full-year guidance amid steady growth.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Johnson & Johnson has shown positive revenue growth over the last two quarters. The revenue increased from $21.89 billion to $23.74 billion, reflecting an average increase of 7.8% per quarter.
Price Rise
In the last 3 months, JNJ stock has moved up by 17.6%
Best in 1 Year
In the last 1 year, JNJ has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 3 years, Procter & Gamble Company, The has given 15.9% return, outperforming this stock by 10.2%
Profit Down
Johnson & Johnson's net profit has decreased for the last two quarters. It fell from $10.99 billion to $5.53 billion, showing an average decrease of 49.7% per quarter.
Organisation | Johnson & Johnson |
Headquarters | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
Industry | Health Technology |
CEO | Mr. Joaquin Duato |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Joaquin Duato | CEO & Chairman |
Mr. Joseph J. Wolk CPA | Executive VP & CFO |
Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine |
Mr. Darren Snellgrove | Vice President of Investor Relations |
Mr. Dirk Brinckman | Chief Compliance Officer |
Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine, R&D |
Mr. Timothy Schmid | Executive VP & Worldwide Chairman of MedTech |
Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer |
Mr. James Swanson | Executive VP & Chief Information Officer |
Ms. Elizabeth Forminard J.D. | Executive VP & Chief Legal Officer |
Johnson & Johnson share price today is $175.62 as on . Johnson & Johnson share today touched a day high of $177.02 and a low of $175.37.
Johnson & Johnson share touched a 52 week high of $181.16 on and a 52 week low of $140.68 on . Johnson & Johnson stock price today i.e. is trending at $175.62,which is 3.06% down from its 52 week high and 24.84% up from its 52 week low.
Johnson & Johnson market capitalisation is $0.43T as on .
Indian investors can start investing in Johnson & Johnson (JNJ) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Johnson & Johnson stock (as per the Rupee-Dollar exchange rate as on ).
Based on Johnson & Johnson share’s latest price of $175.62 as on September 18, 2025 at 9:37 pm IST, you will get 0.0569 shares of Johnson & Johnson. Learn more about
fractional shares .
Johnson & Johnson stock has given 18.78% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?